Comorbidity of psychotic disorder and substance use disorder in a psychiatry inpatient unit: A retrospective study
Objective: Comorbidity of psychotic disorder and substance use disorder is common. Studies demonstrate that this comorbidity constitutes a major mental health problem. The aim of this study is to investigate sociodemographic and clinical differences between illicit drug users and non-users in h...
Main Authors: | , , |
---|---|
Format: | Article |
Language: | English |
Published: |
ANP Publishing
2018-06-01
|
Series: | Klinik Psikiyatri Dergisi |
Subjects: | |
Online Access: | https://www.journalagent.com/kpd/pdfs/KPD-29491-RESEARCH_ARTICLE-ALDEMIR.pdf |
Summary: | Objective: Comorbidity of psychotic disorder and substance
use disorder is common. Studies demonstrate that
this comorbidity constitutes a major mental health problem.
The aim of this study is to investigate sociodemographic
and clinical differences between illicit drug users
and non-users in hospitalised male patients diagnosed
with psychotic disorder. Method: This was a retrospective
study evaluating files of 237 inpatients treated
between January 2013 and December 2016 in Ege
University Department of Psychiatry Male Inpatient Unit
with diagnosis of Schizophrenia Spectrum and Other
Psychotic Disorders according to DSM-5. Results: Of 237
participants, 16% had a lifetime use of an illicit drug.
Participants with substance use disorder had a smaller
mean age and shorter duration of education than participants
without substance use disorder. Of all the participants
with a history of substance use, 76.3% had a
history of substance use in the first episode of psychosis.
The most preferred substance in 72.4% of the participants
with substance use during the first psychotic
episode and in 68.4% of all the participants with substance
use was cannabis. Treatment compliance was
worse in the participants with substance use.
Discussion: Our findings show that, when psychotic disorder
is comorbid with substance use disorder, age of
onset of psychotic symptoms decreases, duration of education
shortens and treatment compliance deteriorates.
These results should be supported by longitudinal studies
using quantitative analysis methods. |
---|---|
ISSN: | 1302-0099 2146-7153 |